80 related articles for article (PubMed ID: 17113149)
21. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Pellagatti A; Marafioti T; Paterson JC; Malcovati L; Della Porta MG; Jädersten M; Pushkaran B; George TI; Arber DA; Killick S; Giagounidis A; Hellström-Lindberg E; Cazzola M; Wainscoat JS; Boultwood J
Br J Haematol; 2009 Jun; 146(1):86-90. PubMed ID: 19438482
[TBL] [Abstract][Full Text] [Related]
22. Diffuse aggressive B-cell lymphomas.
Said J
Adv Anat Pathol; 2009 Jul; 16(4):216-35. PubMed ID: 19546610
[TBL] [Abstract][Full Text] [Related]
23. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
24. Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesis.
Bueno C; Lopes LF; Greaves M; Menendez P
Exp Hematol; 2007 Oct; 35(10):1477-8. PubMed ID: 17681665
[No Abstract] [Full Text] [Related]
25. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone.
Mak IW; Cowan RW; Popovic S; Colterjohn N; Singh G; Ghert M
Bone; 2009 Aug; 45(2):377-86. PubMed ID: 19422937
[TBL] [Abstract][Full Text] [Related]
27. Robertsonian translocation (13;14)(q10;q10) in two young male myelodysplastic syndrome patients.
Bakshi SR; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Joshi MS; Shukla SN; Shah PM
Cancer Genet Cytogenet; 2006 Dec; 171(2):130-1. PubMed ID: 17116494
[No Abstract] [Full Text] [Related]
28. [Impaired expression of genes regulating homeostasis of stem hemopoietic cells in stromal cells of patients with aplastic anemia].
Petrova TV; Nifontova IN; Svinareva DA; Vinogradova MA; Mikhaĭlova EA; Drize NI
Ter Arkh; 2008; 80(1):61-5. PubMed ID: 18326231
[TBL] [Abstract][Full Text] [Related]
29. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
30. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
31. Gene expression analysis at the single cell level using the human bone marrow stromal cell as a model: sample preparation methods.
Seshi B
Methods Mol Biol; 2008; 449():117-32. PubMed ID: 18370088
[TBL] [Abstract][Full Text] [Related]
32. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
[TBL] [Abstract][Full Text] [Related]
33. Exome sequencing takes centre stage in cancer profiling.
Maher B
Nature; 2009 May; 459(7244):146-7. PubMed ID: 19444175
[No Abstract] [Full Text] [Related]
34. Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy.
Nowak D; Nolte F; Mossner M; Nowak V; Baldus CD; Hopfer O; Noll S; Thiel E; Wagner F; Hofmann WK
Exp Hematol; 2009 Feb; 37(2):215-224. PubMed ID: 19135900
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
Boultwood J; Pellagatti A; Cattan H; Lawrie CH; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Hellström-Lindberg E; Wainscoat JS
Br J Haematol; 2007 Nov; 139(4):578-89. PubMed ID: 17916100
[TBL] [Abstract][Full Text] [Related]
36. Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes.
Niscola P; Maurillo L; Palombi M; Fratoni S; Perrotti AP; Piccioni D; Panetta P; Scaramucci L; Del Poeta G; de Fabritiis P
Acta Haematol; 2007; 118(3):165-6. PubMed ID: 17890850
[No Abstract] [Full Text] [Related]
37. Philadelphia-positive
Kushwaha R; Verma SP; Yadav G
Indian J Cancer; 2021; 58(3):463-468. PubMed ID: 34380833
[No Abstract] [Full Text] [Related]
38. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
Stirewalt DL; Mhyre AJ; Marcondes M; Pogosova-Agadjanyan E; Abbasi N; Radich JP; Deeg HJ
Br J Haematol; 2008 Feb; 140(4):444-53. PubMed ID: 18162123
[TBL] [Abstract][Full Text] [Related]
39. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
Miller LD; Liu ET
Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
[TBL] [Abstract][Full Text] [Related]
40. Revealing the pathogenesis of the 5q- syndrome.
Valent P
Eur J Clin Invest; 2008 Aug; 38(8):539-40. PubMed ID: 18717823
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
